Hughes, B., Grob, J.-J. , Bowyer, S., Day, F. , Ladwa, R., Stein, B. , Muñoz-Couselo, E., Basset-Seguin, N., Guminski, A. , Mortier, L. , Hauschild, A. , Migden, M. , Schmults, C. , Yoo, S.-Y., Booth, J. , Seebach, F. , Lowy, I. , Fury, M. and Rischin, D. 2023. Phase 2 confirmatory study of cemiplimab (350 mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s175. DOI:https://doi.org/10.25251/skin.7.supp.175.